Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Long-Term Deferred Tax: 2022-2025

Historic Long-Term Deferred Tax for Harmony Biosciences Holdings (HRMY) over the last 3 years, with Sep 2025 value amounting to $157.1 million.

  • Harmony Biosciences Holdings' Long-Term Deferred Tax fell 15.10% to $157.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.1 million, marking a year-over-year decrease of 15.10%. This contributed to the annual value of $190.4 million for FY2024, which is 32.07% up from last year.
  • Harmony Biosciences Holdings' Long-Term Deferred Tax amounted to $157.1 million in Q3 2025, which was down 21.93% from $201.2 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Long-Term Deferred Tax's 5-year high stood at $201.2 million during Q2 2025, with a 5-year trough of $81.7 million in Q3 2022.
  • For the 3-year period, Harmony Biosciences Holdings' Long-Term Deferred Tax averaged around $153.1 million, with its median value being $157.1 million (2025).
  • In the last 5 years, Harmony Biosciences Holdings' Long-Term Deferred Tax soared by 92.55% in 2024 and then fell by 15.10% in 2025.
  • Harmony Biosciences Holdings' Long-Term Deferred Tax (Quarterly) stood at $85.9 million in 2022, then spiked by 67.74% to $144.2 million in 2023, then surged by 32.07% to $190.4 million in 2024, then decreased by 15.10% to $157.1 million in 2025.
  • Its Long-Term Deferred Tax stands at $157.1 million for Q3 2025, versus $201.2 million for Q2 2025 and $194.7 million for Q1 2025.